Evidence map›Paper›PMID 31094084›Full record

ArticleJournal of biomedical materials research. Part A2019

Functional remodeling of an electrospun polydimethylsiloxane-based polyether urethane external vein graft support device in an ovine model.

Mohammed El-Kurdi, Lorenzo Soletti, Jonathan McGrath, Stephen Linhares, Serge Rousselle, Howard Greisler, Elazer Edelman, Frederick J Schoen

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Mohammed El-KurdiNeograft Technologies, Inc., Taunton, Massachusetts.
Lorenzo SolettiNeograft Technologies, Inc., Taunton, Massachusetts.
Jonathan McGrathNeograft Technologies, Inc., Taunton, Massachusetts.
Stephen LinharesNeograft Technologies, Inc., Taunton, Massachusetts.
Serge RousselleAlizee Pathology, Thurmont, Maryland.
Howard GreislerLoyola University, Maywood, Illinois.
Elazer EdelmanMassachusetts Institute of Technology, Cambridge, Massachusetts.
Frederick J SchoenHarvard Medical School, Boston, Massachusetts.
Applied NanoFemto Technologies (United States) · USAlign Technology (United States) · USHarvard University · USLoyola University Chicago · USMassachusetts Institute of Technology · US

Funding

Vascular Drug Delivery - Supplement for EquipmentR01GM049039 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI EDELMAN, ELAZER R · 1994 to 2019
$8.9M
Neograft TechnologiesNIGMS NIH HHS R01 GM049039
6 · The paper itself

Abstract

Saphenous vein graft (SVG) failure rates are unacceptably high, and external mechanical support may improve patency. We studied the histologic remodeling of a conformal, electrospun, polydimethylsiloxane-based polyether urethane external support device for SVGs and evaluated graft structural evolution in adult sheep to 2 years. All sheep (N = 19) survived to their intended timepoints, and angiography showed device-treated SVG geometric stability over time (30, 90, 180, 365, or 730 days), with an aggregated graft patency rate of 92%. There was minimal inflammation associated with the device material at all timepoints. By 180 days, treated SVG remodeling was characterized by minimal/nonprogressive intimal hyperplasia; polymer fragmentation and integration; as well as the development of a neointima, and a confluent endothelium. By 1-year, the graft developed a media-like layer by remodeling the neointima, and elastic fibers formed well-defined structures that subtended the neo-medial layer of the remodeled SVG. Immunohistochemistry showed that this neo-media was populated with smooth muscle cells, and the intima was lined with endothelial cells. These data suggest that treated SVGs were structurally remodeled by 180 days, and developed arterial-like features by 1 year, which continued to mature to 2 years. Device-treated SVGs remodeled into arterial-like conduits with stable long-term performance as arterial grafts in adult sheep.

Indexed as

AngiographyAnimalsBlood Vessel Prosthesis ImplantationDimethylpolysiloxanesInflammationModels, AnimalPhagocytosisPlatelet Endothelial Cell Adhesion Molecule-1PolyurethanesSaphenous VeinSheepVascular Graftingvon Willebrand FactorbaysilonDimethylpolysiloxanesPlatelet Endothelial Cell Adhesion Molecule-1polyetherurethanePolyurethanesvon Willebrand Factorbiomaterial remodelingenvironmental stress crackingexternal stentpolydimethylsiloxane polyether urethanesaphenous vein graft

Identifiers

PMID31094084
PMCPMC6689261
OpenAlexW2946372328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.